Literature DB >> 10603121

End-stage renal disease in two pediatric patients with Fechtner syndrome.

M M Moxey-Mims1, G Young, A Silverman, D M Selby, J G White, K K Kher.   

Abstract

Fechtner syndrome, a disease in the spectrum of the hereditary nephridites, is a macrothrombocytopenia associated with sensorineural hearing loss, cataracts, nephritis, and characteristic leukocyte inclusions. Renal biopsy findings are consistent with those of Alport syndrome, and the associated renal disease is said to be unusual before mid to late adulthood. Here, we review the available literature on this disease and report two African-American pediatric patients with Fechtner syndrome who rapidly progressed to end-stage renal disease during adolescence. We conclude that chronic renal failure can occur at a young age in patients with Fechtner syndrome, with a possible relation to race/ethnicity. Fechtner syndrome, or other variants of Alport syndrome, need to be considered in patients presenting with proteinuria and thrombocytopenia.

Entities:  

Mesh:

Year:  1999        PMID: 10603121     DOI: 10.1007/s004670050700

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  4 in total

1.  Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism?

Authors:  Jeffrey B Kopp
Journal:  Kidney Int       Date:  2010-07       Impact factor: 10.612

2.  Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.

Authors:  K E Heath; A Campos-Barros; A Toren; G Rozenfeld-Granot; L E Carlsson; J Savige; J C Denison; M C Gregory; J G White; D F Barker; A Greinacher; C J Epstein; M J Glucksman; J A Martignetti
Journal:  Am J Hum Genet       Date:  2001-10-04       Impact factor: 11.025

Review 3.  Essential hypertension and risk of nephropathy: a reappraisal.

Authors:  Mariana Murea; Barry I Freedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

4.  MYH9-related disorders display heterogeneous kidney involvement and outcome.

Authors:  Nahid Tabibzadeh; Dominique Fleury; Delphine Labatut; Frank Bridoux; Arnaud Lionet; Noémie Jourde-Chiche; François Vrtovsnik; Nicole Schlegel; Philippe Vanhille
Journal:  Clin Kidney J       Date:  2018-12-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.